94 related articles for article (PubMed ID: 2972671)
1. Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
Chang HR; Rudareanu FC; Pechère JC
J Antimicrob Chemother; 1988 Sep; 22(3):359-61. PubMed ID: 2972671
[TBL] [Abstract][Full Text] [Related]
2. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
Araujo FG; Shepard RM; Remington JS
Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.
Araujo FG; Guptill DR; Remington JS
Antimicrob Agents Chemother; 1988 May; 32(5):755-7. PubMed ID: 2840017
[TBL] [Abstract][Full Text] [Related]
4. In-vitro and in-vivo activity of rifabutin against Toxoplasma gondii.
Olliaro P; Gorini G; Jabes D; Regazzetti A; Rossi R; Marchetti A; Tinelli C; Della Bruna C
J Antimicrob Chemother; 1994 Nov; 34(5):649-57. PubMed ID: 7706160
[TBL] [Abstract][Full Text] [Related]
5. Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
Araujo FG; Prokocimer P; Lin T; Remington JS
Antimicrob Agents Chemother; 1992 Nov; 36(11):2454-7. PubMed ID: 1489188
[TBL] [Abstract][Full Text] [Related]
6. Ketolide ABT-773 is active against Toxoplasma gondii.
Khan AA; Araujo FG; Craft JC; Remington JS
J Antimicrob Chemother; 2000 Sep; 46(3):489-92. PubMed ID: 10980181
[TBL] [Abstract][Full Text] [Related]
7. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice.
Mitchell SM; Zajac AM; Davis WL; Lindsay DS
J Parasitol; 2004 Jun; 90(3):639-42. PubMed ID: 15270113
[TBL] [Abstract][Full Text] [Related]
9. Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice.
Araujo FG; Lin T; Remington JS
Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):71-3. PubMed ID: 1314177
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.
Luft BJ
Eur J Clin Microbiol; 1987 Aug; 6(4):479-81. PubMed ID: 3665901
[TBL] [Abstract][Full Text] [Related]
11. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
12. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
Alder J; Hutch T; Meulbroek JA; Clement JC
J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
[TBL] [Abstract][Full Text] [Related]
13. Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection.
Chang HR; Pechère JC
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():87-92. PubMed ID: 3182450
[TBL] [Abstract][Full Text] [Related]
14. Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis.
Araujo FG; Prokocimer P; Remington JS
J Infect Dis; 1992 Apr; 165(4):788. PubMed ID: 1532409
[No Abstract] [Full Text] [Related]
15. Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.
Chan J; Luft BJ
Antimicrob Agents Chemother; 1986 Aug; 30(2):323-4. PubMed ID: 3767344
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice.
Goodwin DG; Strobl J; Mitchell SM; Zajac AM; Lindsay DS
J Parasitol; 2008 Apr; 94(2):555-7. PubMed ID: 18564764
[TBL] [Abstract][Full Text] [Related]
17. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis.
Sordet F; Aumjaud Y; Fessi H; Derouin F
Parasite; 1998 Sep; 5(3):223-9. PubMed ID: 9772721
[TBL] [Abstract][Full Text] [Related]
19. Activity of roxithromycin against Toxoplasma gondii in murine models.
Chang HR; Pechère JC
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():69-74. PubMed ID: 3429388
[TBL] [Abstract][Full Text] [Related]
20. Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis.
Schöler N; Krause K; Kayser O; Müller RH; Borner K; Hahn H; Liesenfeld O
Antimicrob Agents Chemother; 2001 Jun; 45(6):1771-9. PubMed ID: 11353624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]